What it is
CJC-1295 is a synthetic GHRH-analogue peptide designed to stimulate pulsatile release of growth hormone. It is researched for its potential to support cellular longevity and healthy aging processes.
2 mg · vegan · gluten-free · 30 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
CJC-1295 is a synthetic GHRH-analogue peptide designed to stimulate pulsatile release of growth hormone. It is researched for its potential to support cellular longevity and healthy aging processes.
CJC-1295 binds to GHRH receptors in the pituitary gland, mimicking the action of endogenous GHRH to increase the frequency and amplitude of growth hormone pulses. This leads to downstream effects on IGF-1 production and cellular repair mechanisms.
Adults looking to address premature ageing, low energy, cellular stress. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
C · C · emerging-to-moderate human evidence for healthy ageing and cellular longevity
SacredBod's longer take on CJC-1295 — context the structured blocks above don't capture.
CJC-1295 is a peptide supplement used to support healthy ageing and cellular longevity. GHRH-analogue peptide researched for growth-hormone pulse. It is available in capsule form and dosed for adults in India and internationally. As a peptide-tradition entry in the SacredBod catalog, it is positioned as a single-ingredient option that can be used on its own or layered into a broader protocol.
CJC-1295 works through the mechanisms characteristic of its class — see the mechanism and research sections for detail. It primarily acts on the mitochondria, cells, telomeres, and effects are dose-dependent, typically becoming measurable within 8-12 weeks for longevity markers. Consistency matters more than dose size for this category.
Adults looking to address premature ageing, low energy, cellular stress. Particularly relevant for people who prefer a targeted single ingredient and who have ruled out an underlying condition that needs medical care first.
CJC-1295 carries an evidence grade of C in the SacredBod catalog. GHRH-analogue peptide researched for growth-hormone pulse. See the Research panel above for the underlying studies, participant counts and typical effect sizes.
Typical label dose is 2 mg in capsule form. Most adults can expect noticeable effects within 8-12 weeks for longevity markers. Consistency matters more than a single large dose — take it daily and re-evaluate against your blood markers at 8–12 weeks.
Pregnant or nursing women without clinician oversight. People on prescription medication affecting the same pathway should consult a doctor before combining. Side effects are uncommon at recommended doses but mild GI upset can occur when starting.
As part of the Peptide category, CJC-1295 can be used on its own or layered into a broader protocol — see the Goes with panel for synergistic pairings.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
Request received.
We'll route this to a clinician familiar with peptide protocols. Expect a reply within about 48 hours.
How's your experience? We read every note.